O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2

Amino Acids

Volumn 45, Issue 2, 2013, Pages 339-349

  Ding, Fang ^a,b   Yu, Lu ^a   Wang, Meihui ^a   Xu, Shengjie ^a   Xia, Qiang ^c   Fu, Guosheng ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG HOSPITAL   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cardiomyocyte hypertrophy; High glucose; O GlcNAcylation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACETYLGLUCOSAMINIDASE; CYCLIN D2; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; STREPTOZOCIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SIZE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GLYCOSYLATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HYPERGLYCEMIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN O GLCNACYLATION; RAT; STREPTOZOCIN DIABETES;

ACETYLGLUCOSAMINE; ACETYLGLUCOSAMINIDASE; ANIMALS; CARDIOMEGALY; CYCLIN D2; DIABETES MELLITUS, EXPERIMENTAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; GLUCOSE; GLYCOSYLATION; HEART; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; N-ACETYLGLUCOSAMINYLTRANSFERASES; OXIMES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENYLCARBAMATES; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STREPTOZOCIN;

RATTUS;

EID: 84880850374     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-013-1504-2     Document Type: Article

References (68)

1. Ahuja P, Sdek P, MacLellan WR (2007) Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 87:521-544
2. Andres-Bergos J, Tardio L, Larranaga-Vera A, Gomez R, Herrero-Beaumont G, Largo R (2012) The increase in O-linked N-acetylglucosamine protein modification stimulates chondrogenic differentiation both in vitro and in vivo. J Biol Chem 287:33615-33628
3. Angelis E, Garcia A, Chan SS et al (2008) A cyclin D2-Rb pathway regulates cardiac myocyte size and RNA polymerase III after biomechanical stress in adult myocardium. Circ Res 102:1222-1229
4. Bicknell KA, Surry EL, Brooks G (2003) Targeting the cell cycle machinery for the treatment of cardiovascular disease. J Pharm Pharmacol 55:571-591
5. Bueno OF, De Windt LJ, Tymitz KM et al (2000) The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19:6341-6350
6. Busk PK, Hinrichsen R (2003) Cyclin D in left ventricle hypertrophy. Cell Cycle 2:91-95
7. Busk PK, Bartkova J, Strom CC et al (2002) Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro. Cardiovasc Res 56:64-75
8. Busk PK, Hinrichsen R, Bartkova J et al (2005) Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy. Exp Cell Res 304:149-161
9. Champattanachai V, Marchase RB, Chatham JC (2008) Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am J Physiol Cell Physiol 294:C1509-C1520
10. Chen S, Khan ZA, Karmazyn M, Chakrabarti S (2007) Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy. Diabetes Metab Res Rev 23:356-367
11. Chou CF, Omary MB (1993) Mitotic arrest-associated enhancement of O-linked glycosylation and phosphorylation of human keratins 8 and 18. J Biol Chem 268:4465-4472
12. Ciaraldi TP, Carter L, Nikoulina S, Mudaliar S, McClain DA, Henry RR (1999) Glucosamine regulation of glucose metabolism in cultured human skeletal muscle cells: divergent effects on glucose transport/phosphorylation and glycogen synthase in non-diabetic and type 2 diabetic subjects. Endocrinology 140:3971-3980
13. Clark RJ, McDonough PM, Swanson E et al (2003) Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J Biol Chem 278:44230-44237
14. Clerk A, Sugden PH (2001) Untangling the web: specific signaling from PKC isoforms to MAPK cascades. Circ Res 89:847-849
15. Clerk A, Aggeli IK, Stathopoulou K, Sugden PH (2006) Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes. Cell Signal 18:225-235
16. Darley-Usmar VM, Ball LE, Chatham JC (2012) Protein O-linked beta-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function. J Mol Cell Cardiol 52:538-549
17. Dong L, Wang W, Wang F et al (1999) Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells. J Biol Chem 274:32099-32107
18. Du XL, Edelstein D, Rossetti L et al (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 97:12222-12226
19. Dudognon P, Maeder-Garavaglia C, Carpentier JL, Paccaud JP (2004) Regulation of a COPII component by cytosolic O-glycosylation during mitosis. FEBS Lett 561:44-50
20. Facundo HT, Brainard RE, Watson LJ et al (2012) O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy. Am J Physiol Heart Circ Physiol 302:H2122-H2130
21. Fong JJ, Nguyen BL, Bridger R et al (2012) Beta-N-Acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3. J Biol Chem 287:12195-12203
22. Fulop N, Zhang Z, Marchase RB, Chatham JC (2007) Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation. Am J Physiol Heart Circ Physiol 292:H2227-H2236
23. Gong J, Jing L (2011) Glutamine induces heat shock protein 70 expression via O-GlcNAc modification and subsequent increased expression and transcriptional activity of heat shock factor-1. Minerva Anestesiol 77:488-495
24. Hiromura M, Choi CH, Sabourin NA, Jones H, Bachvarov D, Usheva A (2003) YY1 is regulated by O-linked N-acetylglucosaminylation (O-glcNAcylation). J Biol Chem 278:14046-14052
25. Hu Y, Suarez J, Fricovsky E et al (2009) Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. J Biol Chem 284:547-555
26. Jones SP, Zachara NE, Ngoh GA et al (2008) Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation 117:1172-1182
27. Kamemura K, Hayes BK, Comer FI, Hart GW (2002) Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. J Biol Chem 277:19229-19235
28. Kayampilly PP, Menon KM (2012) AMPK activation by dihydrotestosterone reduces FSH-stimulated cell proliferation in rat granulosa cells by inhibiting ERK signaling pathway. Endocrinology 153:2831-2838
29. Kennedy RA, Kemp TJ, Sugden PH, Clerk A (2006) Using U0126 to dissect the role of the extracellular signal-regulated kinase 1/2 (ERK1/2) cascade in the regulation of gene expression by endothelin-1 in cardiac myocytes. J Mol Cell Cardiol 41:236-247
30. Laczy B, Hill BG, Wang K et al (2009) Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system. Am J Physiol Heart Circ Physiol 296:H13-H28
31. LaMorte VJ, Thorburn J, Absher D et al (1994) Gq- and ras-dependent pathways mediate hypertrophy of neonatal rat ventricular myocytes following alpha 1-adrenergic stimulation. J Biol Chem 269:13490-13496
32. Lefebvre T, Baert F, Bodart JF, Flament S, Michalski JC, Vilain JP (2004) Modulation of O-GlcNAc glycosylation during Xenopus oocyte maturation. J Cell Biochem 93:999-1010
33. Li JM, Poolman RA, Brooks G (1998) Role of G1 phase cyclins and cyclin-dependent kinases during cardiomyocyte hypertrophic growth in rats. Am J Physiol 275:H814-H822
34. Lim KH, Chang HI (2006) O-linked N-acetylglucosamine suppresses thermal aggregation of Sp1. FEBS Lett 580:4645-4652
35. Lima VV, Giachini FR, Carneiro FS et al (2008) Increased vascular O-GlcNAcylation augments reactivity to constrictor stimuli - VASOACTIVE PEPTIDE SYMPOSIUM. J Am Soc Hypertens. 2:410-417
36. Lima VV, Giachini FR, Choi H et al (2009) Impaired vasodilator activity in deoxycorticosterone acetate-salt hypertension is associated with increased protein O-GlcNAcylation. Hypertension 53:166-174
37. Liu J, Pang Y, Chang T, Bounelis P, Chatham JC, Marchase RB (2006) Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. J Mol Cell Cardiol 40:303-312
38. Liu J, Marchase RB, Chatham JC (2007) Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis. Am J Physiol Heart Circ Physiol 293:H1391-H1399
39. Lunde IG, Aronsen JM, Kvaloy H et al (2012) Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure. Physiol Genomics 44:162-172
40. Luo B, Soesanto Y, McClain DA (2008) Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells. Arterioscler Thromb Vasc Biol 28:651-657
41. Marsh SA, Dell'Italia LJ, Chatham JC (2011) Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice. Amino Acids 40:819-828
42. Marshall S, Nadeau O, Yamasaki K (2004) Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: differential effects on glucosamine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels. J Biol Chem 279:35313-35319
43. Medford HM, Chatham JC, Marsh SA (2012) Chronic ingestion of a Western diet increases O-linked-beta-N-acetylglucosamine (O-GlcNAc) protein modification in the rat heart. Life Sci 90:883-888
44. Murarka S, Movahed MR (2010) Diabetic cardiomyopathy. J Card Fail 16:971-979
45. Musicki B, Kramer MF, Becker RE, Burnett AL (2005) Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc Natl Acad Sci USA 102:11870-11875
46. 2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine. Am J Physiol Cell Physiol 290:C57-C65
47. Ngoh GA, Watson LJ, Facundo HT, Dillmann W, Jones SP (2008) Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition. J Mol Cell Cardiol 45:313-325
48. Ngoh GA, Watson LJ, Facundo HT, Jones SP (2011) Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes. Amino Acids 40:895-911
49. Piatelli MJ, Doughty C, Chiles TC (2002) Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes. J Biol Chem 277:12144-12150
50. Rolo AP, Palmeira CM (2006) Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 212:167-178
51. Roquemore EP, Chevrier MR, Cotter RJ, Hart GW (1996) Dynamic O-GlcNAcylation of the small heat shock protein alpha B-crystallin. Biochemistry 35:3578-3586
52. Singh AB, Guleria RS, Nizamutdinova IT, Baker KM, Pan J (2012) High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling. J Cell Physiol 227:2632-2644
53. Slawson C, Shafii S, Amburgey J, Potter R (2002) Characterization of the O-GlcNAc protein modification in Xenopus laevis oocyte during oogenesis and progesterone-stimulated maturation. Biochim Biophys Acta 1573:121-129
54. Slawson C, Zachara NE, Vosseller K, Cheung WD, Lane MD, Hart GW (2005) Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J Biol Chem 280:32944-32956
55. Slawson C, Lakshmanan T, Knapp S, Hart GW (2008) A mitotic GlcNAcylation/phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin. Mol Biol Cell 19:4130-4140
56. Tomlinson DR (1999) Mitogen-activated protein kinases as glucose transducers for diabetic complications. Diabetologia 42:1271-1281
57. Torres CR, Hart GW (1984) Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem 259:3308-3317
58. Tsai KH, Wang WJ, Lin CW et al (2012) NADPH oxidase-derived superoxide anion-induced apoptosis is mediated via the JNK-dependent activation of NF-kappaB in cardiomyocytes exposed to high glucose. J Cell Physiol 227:1347-1357
59. Virkamaki A, Yki-Jarvinen H (1999) Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart. Diabetes 48:1101-1107
60. Wang Y (2001) Signal transduction in cardiac hypertrophy-dissecting compensatory versus pathological pathways utilizing a transgenic approach. Curr Opin Pharmacol 1:134-140
61. Wells L, Slawson C, Hart GW (2011) The E2F-1 associated retinoblastoma-susceptibility gene product is modified by O-GlcNAc. Amino Acids 40:877-883
62. Whelan SA, Hart GW (2003) Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation. Circ Res 93:1047-1058
63. Xin X, Khan ZA, Chen S, Chakrabarti S (2004) Extracellular signal-regulated kinase (ERK) in glucose-induced and endothelin-mediated fibronectin synthesis. Lab Invest 84:1451-1459
64. Yang Y, Ago T, Zhai P, Abdellatif M, Sadoshima J (2011) Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7. Circ Res 108:305-313
65. Yu L, Zhao Y, Fan Y, Wang M, Xu S, Fu G (2010) Epigallocatechin-3 gallate, a green tea catechin, attenuated the downregulation of the cardiac gap junction induced by high glucose in neonatal rat cardiomyocytes. Cell Physiol Biochem 26:403-412
66. Zachara NE, O'Donnell N, Cheung WD, Mercer JJ, Marth JD, Hart GW (2004) Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem 279:30133-30142
67. Zhong W, Mao S, Tobis S et al (2006) Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathway. EMBO J 25:3869-3879
68. Zou L, Yang S, Champattanachai V et al (2009) Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling. Am J Physiol Heart Circ Physiol 296:H515-H523